The global non-invasive aesthetic treatment market is projected to reach a size of US$ 39.75 billion in 2024, according to the recently updated market analysis complied by proficient analysts at Fact.MR. Revenue from non-invasive aesthetic treatment solutions is approximated to increase at 20.7% CAGR and reach US$ 260 billion by the end of 2034.
Increasing focus of people around the world on physical appearance is leading to the growing demand for non-invasive aesthetic treatment solutions. Another prominent revenue generator is people from different age groups seeking these procedures, especially those aged 50 and above, particularly women who are opting for injectables and filters, such as Botox. Increasing count of non-invasive cosmetic surgeries due to their reduced downtime and less risk compared to conventional surgical alternatives are creating prospects for market players.
For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7162
Key Takeaways from the Market Study:
-Global Non-Invasive aesthetic market is expected to reach a market size of US$ 61.4 Bn by 2022.
-In 2022, North America to contribute more than 40% of market revenue.
-Injectables are expected to account for 63.3% of the market revenue in 2022.
-Skin rejuvenation is estimated to be over US$ 15.55 Bn in 2022, growing a CAGR of over 15.5% for the forecast period.
-North America is expected to experience a CAGR of 16.1% across the 2022–2032 forecast period.
In Non-Invasive Aesthetic Treatment Market Kybella, an injectable is gaining the attention as Kybella is a fat-dissolving injection that works on a targeted treatment region. It is a synthetic variant of deoxycholic acid that can damage fat cell membranes. In 2015, the FDA approved the therapy for treating under-chin fat, comments a Fact.MR analyst.
Competitive Analysis:
Key players in the non-invasive aesthetic treatment market are focusing on growth strategies such as Improvement of existing technology, geographic expansion, product launch and product approval, to gain higher market share. Various development strategies help raise consumer awareness of new processes and products, such as product launches and collaborations. Key players in the non-invasive aesthetic treatment market are focusing on growth strategies such as Improvement of existing technology, geographic expansion, product launch and product approval, to gain higher market share. Various development strategies help raise consumer awareness of new processes and products, such as product launches and collaborations.
In September, 2021 Lumenis, completed the US$ 1 billion sale of its surgical division to Boston Scientific Corporation, a medical device manufacturer. Lumenis intends to refocus and accelerate planned investments to support the growth of its fast-growing Aesthetic and Vision businesses, with a focus on R&D, worldwide sales and marketing channels, and business development.
In January 2021, Galderma launched Face for Change in partnership with The Skin Cancer Foundation and Dress for Success in the United States.
In October 2020, Alma introduced its newest Alma Hybrid platform, which is aimed to investigate several options for using ablative, non-ablative, and thermal therapies on skin rejuvenation and scar revision, as well as assess their synergistic effects. As a result, the market is being fuelled by the availability of user-friendly, technologically improved non-invasive aesthetic treatment solutions.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7162
Key Companies Profiled:
-Hologic, Inc.
-Allergan, Inc.
-Galderma S.A.
-Alma Lasers
-Syneron Candela
Johnson & Johnson
MerzPharma
Lumenis
Solta Medical
Cutera Inc.
Revance Therapeutics Inc.
Country-wise Analysis:
The United States stands as the dominant force in the realm of non-invasive treatments, not only within North America but also on a global scale. This prominence is reinforced by data from the International Society of Aesthetic Plastic Surgery, which underscores the United States’ pivotal role as a key market for non-invasive surgical procedures. Furthermore, the burgeoning popularity of injectables is a pivotal driver propelling market growth to new heights.
Within the United States, several factors converge to fuel this robust market. A heightened awareness regarding the diverse array of available non-invasive aesthetic treatments, an increased emphasis on beauty consciousness, and the presence of substantial disposable income levels collectively steer the market’s trajectory. Moreover, the nation benefits from a commendable pool of proficient and seasoned surgeons, a factor that has significantly contributed to the widespread acceptance of aesthetic treatments. A testimony to this is the data furnished by the International Society of Aesthetic Plastic Surgery, which reported the presence of approximately 7,000 plastic surgeons in the United States as of 2019.